Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S B Moore

Showing results (101-110 of 160) with videos related to

Pageof 16
Sort By:
Mayo Clinic Proceedings|August 1, 1979
Heterogeneity of HLA-BW35 based on the diallelic BW4-BW6 systemS R DeGoey, S B Moore, S K Watts, et al.
Vox Sanguinis|January 1, 1984
Transfusion-induced alloimmunization in patients awaiting renal allograftsS B Moore, S Sterioff, A M Pierides, et al.
The American Journal of Gastroenterology|December 17, 1997
Genetic distinctions between types 1 and 2 autoimmune hepatitisA J Czaja, M Kruger, P J Santrach, et al.
Journal of Clinical Apheresis|July 27, 2004
Plasma exchange conditioning for ABO-incompatible renal transplantationJ L Winters, J M Gloor, A A Pineda, et al.
Hepatology (Baltimore, Md.)|September 1, 1987
Primary biliary cirrhosis: associations with class II major histocompatibility complex antigensG J Gores, S B Moore, L D Fisher, et al.
Gastroenterology|June 1, 1993
The nature and prognosis of severe cryptogenic chronic active hepatitisA J Czaja, H A Carpenter, P J Santrach, et al.
Digestive Diseases and Sciences|September 30, 1998
Immune phenotype of chronic liver diseaseA J Czaja, R M dos Santos, A Porto, et al.
Mayo Clinic Proceedings|April 1, 1984
A study of HLA antigens in alcoholismD M Robertson, R M Morse, S B Moore, et al.
Clinical Nephrology|November 1, 1980
In search of marker for genetic susceptibility to reflux nephropathyV E Torres, S B Moore, S B Kurtz, et al.
Clinical Nephrology|March 1, 1997
Antagonists of cyclic nucleotide phosphodiesterase (PDE) isozymes PDE 3 and PDE 4 suppress lymphoblastic response to HLA class II alloantigens: a potential novel approach to preventing allograft rejection?M K Dousa, S B Moore, N A Ploeger, et al.
Pageof 16

Showing results (101-110 of 160) with videos related to

Sort By:
Pageof 16
Mayo Clinic Proceedings|August 1, 1979
Heterogeneity of HLA-BW35 based on the diallelic BW4-BW6 systemS R DeGoey, S B Moore, S K Watts, et al.
Vox Sanguinis|January 1, 1984
Transfusion-induced alloimmunization in patients awaiting renal allograftsS B Moore, S Sterioff, A M Pierides, et al.
The American Journal of Gastroenterology|December 17, 1997
Genetic distinctions between types 1 and 2 autoimmune hepatitisA J Czaja, M Kruger, P J Santrach, et al.
Journal of Clinical Apheresis|July 27, 2004
Plasma exchange conditioning for ABO-incompatible renal transplantationJ L Winters, J M Gloor, A A Pineda, et al.
Hepatology (Baltimore, Md.)|September 1, 1987
Primary biliary cirrhosis: associations with class II major histocompatibility complex antigensG J Gores, S B Moore, L D Fisher, et al.
Gastroenterology|June 1, 1993
The nature and prognosis of severe cryptogenic chronic active hepatitisA J Czaja, H A Carpenter, P J Santrach, et al.
Digestive Diseases and Sciences|September 30, 1998
Immune phenotype of chronic liver diseaseA J Czaja, R M dos Santos, A Porto, et al.
Mayo Clinic Proceedings|April 1, 1984
A study of HLA antigens in alcoholismD M Robertson, R M Morse, S B Moore, et al.
Clinical Nephrology|November 1, 1980
In search of marker for genetic susceptibility to reflux nephropathyV E Torres, S B Moore, S B Kurtz, et al.
Clinical Nephrology|March 1, 1997
Antagonists of cyclic nucleotide phosphodiesterase (PDE) isozymes PDE 3 and PDE 4 suppress lymphoblastic response to HLA class II alloantigens: a potential novel approach to preventing allograft rejection?M K Dousa, S B Moore, N A Ploeger, et al.
Pageof 16